|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 25.35 USD | -4.12% |
|
-6.49% | -45.25% |
| 08-13 | Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement | MT |
| 08-06 | Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026 | CI |
Company Valuation: Collegium Pharmaceutical, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 650 | 778.9 | 1,004 | 924 | 1,464 | 825.3 | - | - |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -43.61% | - | - |
| Enterprise Value (EV) | 650 | 778.9 | 1,004 | 924 | 1,464 | 825.3 | 825.3 | 825.3 |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -43.61% | 0% | 0% |
| P/E | 10x | -31.4x | 23.9x | 15.4x | 26.8x | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | -0x | 0.3x | -3.83x | - | - | - |
| Capitalization / Revenue | 2.35x | 1.68x | 1.77x | 1.46x | 1.88x | 0.99x | 1x | 1.01x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.99x | 1x | 1.01x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.81x | 2.07x | 2.41x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 1.83x | 2.04x | 2.19x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.86 | -0.74 | 1.29 | 1.86 | 1.73 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 276.9 | 463.9 | 566.8 | 631.4 | 780.6 | 836.8 | 828.1 | 820.2 |
| EBITDA 1 | 118.3 | 266 | 367 | 401.2 | 460.5 | 455.8 | 399.4 | 342.7 |
| EBIT 1 | 17.63 | 33.32 | 167 | 169.9 | 179.6 | 450.8 | 404.7 | 376.5 |
| Net income | 71.52 | -25 | 48.16 | 69.19 | 62.87 | - | - | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.68 | 23.20 | 30.78 | 28.65 | 46.30 | 25.35 | 25.35 | 25.35 |
| Nbr of stocks (in thousands) | 34,797 | 33,572 | 32,611 | 32,250 | 31,611 | 32,556 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/22/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 861M | |
| 33.48x | 12.15x | 24.63x | 0.59% | 1,048B | |
| 29.56x | - | - | 2.02% | 640B | |
| 32.95x | 7.64x | 15.89x | 2.66% | 456B | |
| 20.28x | 4.82x | 11.94x | 2.74% | 362B | |
| 22.04x | 5.68x | 14.08x | 2.82% | 295B | |
| 21.17x | 4.34x | 12.4x | 2.03% | 255B | |
| 27.64x | 7.13x | 12.67x | 2.31% | 236B | |
| 13.24x | 4.76x | 9.94x | 3.83% | 204B | |
| -45.49x | 6.56x | 25.62x | 2.21% | 185B | |
| Average | 17.21x | 6.64x | 15.90x | 2.36% | 368.25B | |
| Weighted average by Cap. | 24.21x | 8.10x | 17.91x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLL Stock
- Valuation Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
